©The Author(s) 2025.
World J Clin Oncol. Dec 24, 2025; 16(12): 112443
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112443
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112443
Figure 1 Distribution of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures performed for peritoneal metastases from uncommon histologies across three consecutive periods (2004-2010, 2011-2016, 2017-2021), stratified by tumor origin.
Female neoplasms (breast and uterine cancer) were more common in earlier years, whereas procedures for other primary tumors increased over time. PM: Peritoneal metastases; UH: Uncommon histologies.
- Citation: Framarini M, D'Acapito F, Lippolis PV, Di Giorgio A, Di Pietrantonio D, Sommariva A, Sammartino P. Expanding the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study on uncommon peritoneal malignancies. World J Clin Oncol 2025; 16(12): 112443
- URL: https://www.wjgnet.com/2218-4333/full/v16/i12/112443.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i12.112443